Safeguard Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>SS</div>
SFE -- USA Stock  

USD 6.43  0.02  0.31%

The predictive indicators we use to evaluate Safeguard help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Safeguard Scientifics Inc. We apply different methods to arrive at the intrinsic value of Safeguard based on widely used predictive technical indicators. Let's try to digest what's happening with Safeguard Scientifics amid unprecedented political, and economic uncertainty.
Published over a month ago
View all stories for Safeguard Scientifics | View All Stories
Do you have a personal attachment to Safeguard Scientifics?
We provide advice to complement the current expert consensus on Safeguard Scientifics. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time.
The successful prediction of Safeguard Scientifics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Safeguard Scientifics Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Safeguard Scientifics based on Safeguard Scientifics hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Safeguard Scientifics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Safeguard Scientifics's related companies.

Use Technical Analysis to project Safeguard expected Price

Safeguard Scientifics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Safeguard Scientifics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Safeguard Scientifics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How Safeguard utilizes its cash?

To perform a cash flow analysis of Safeguard Scientifics, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Safeguard Scientifics is receiving and how much cash it distributes out in a given period. The Safeguard Scientifics cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Safeguard Scientifics Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (19.97 Million)

What is driving Safeguard Scientifics Investor Appetite?

The company reported the last year's revenue of 34.84 M. Reported Net Loss for the year was (29.11 M) with profit before taxes, overhead, and interest of 57.71 M.
 2019 2020 (projected)
Interest Expense4.07 M5.88 M
Gross Profit18.93 M19.42 M

Deferred Revenue Breakdown

Safeguard Scientifics Deferred Revenue is decreasing over the years with stable fluctuation. Ongoing Deferred Revenue is projected to grow to about 5.4 M this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Safeguard Scientifics Deferred Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Deferred Revenue was at 4.09 Million
2010
2011
2019
2020
20109.61 Million
20113.56 Million
20194.09 Million
20205.38 Million

Our take on Safeguard Scientifics small dip

Safeguard Scientifics latest coefficient of variation ascents over 3329.33. Safeguard Scientifics Inc currently demonstrates below-verage downside deviation. It has Information Ratio of -0.01 and Jensen Alpha of 0.08. However, we do advice investors to further question Safeguard Scientifics Inc expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

Our Takeaway on Safeguard Scientifics Investment

When is the right time to buy or sell Safeguard Scientifics Inc? Buying stocks such as Safeguard Scientifics isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily bases. On the whole, as of the 25th of October 2020, our research shows that Safeguard Scientifics is a rather slightly risky investment opportunity with a very low chance of bankruptcy in the next two years. From a slightly different view, the entity currently appears to be overvalued. Our primary 30 days recommendation on the firm is Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Safeguard Scientifics Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com